How to manage occult atrial fibrillation detected on long-term monitoring

Circulation

Volumn 133, Issue 13, 2016, Pages 1290-1295

  Lip, Gregory Y H ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RISK; CASE REPORT; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAPHY MONITORING; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LONG TERM CARE; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OCCULT ATRIAL FIBRILLATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; AMBULATORY ELECTROCARDIOGRAPHY; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE MANAGEMENT; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PROCEDURES; TIME FACTOR;

ANIMALS; ATRIAL FIBRILLATION; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; TIME FACTORS;

EID: 84962494970     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.016797     Document Type: Article

References (24)

1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines-CPG; Document Reviewers 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012 14 1385 1413. doi: 10.1093/europace/eus305.
2. Ritter MA, Kochhäuser S, Duning T, Reinke F, Pott C, Dechering DG, Eckardt L, Ringelstein EB, Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013 44 1449 1452. doi: 10.1161/STROKEAHA.111.676189.
3. Keach JW, Bradley SM, Turakhia MP, Maddox TM, Early detection of occult atrial fibrillation and stroke prevention. Heart 2015 101 1097 1102. doi: 10.1136/heartjnl-2015-307588.
4. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M, EMBRACE Investigators and Coordinators Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014 370 2467 2477. doi: 10.1056/NEJMoa1311376.
5. Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V, Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2015 14 377 387. doi: 10.1016/S1474-4422(15)70027-X.
6. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005 149 657 663. doi: 10.1016/j.ahj.2004.06.032.
7. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH, ASSERT Investigators Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012 366 120 129. doi: 10.1056/NEJMoa1105575.
8. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ, Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001 285 2864 2870
9. Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, Ip J, Holcomb R, Akar JG, Halperin JL, IMPACT Investigators Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 2015 36 1660 1668. doi: 10.1093/eurheartj/ehv115.
10. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD, The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009 2 474 480. doi: 10.1161/CIRCEP.109.849638.
11. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G, Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009 20 241 248. doi: 10.1111/j.1540-8167.2008.01320.x.
12. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J, CRYSTAL AF Investigators Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014 370 2478 2486. doi: 10.1056/NEJMoa1313600.
13. Sposato LA, Cipriano LE, Riccio PM, Hachinski V, Saposnik G, Very short paroxysms account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta-analysis. Int J Stroke 2015 10 801 807. doi: 10.1111/ijs.12555.
14. Li L, Yiin GS, Geraghty OC, Schulz UG, Kuker W, Mehta Z, Rothwell PM, Oxford Vascular Study Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol 2015 14 903 913. doi: 10.1016/S1474-4422(15)00132-5.
15. Favilla CG, Ingala E, Jara J, Fessler E, Cucchiara B, Messé SR, Mullen MT, Prasad A, Siegler J, Hutchinson MD, Kasner SE, Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke 2015 46 1210 1215. doi: 10.1161/STROKEAHA.114.007763.
16. Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chen TJ, Lip GY, Chen SA, Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? J Am Coll Cardiol 2015 65 635 642. doi: 10.1016/j.jacc.2014.11.046.
17. Lip GY, Skjøth F, Rasmussen LH, Larsen TB, Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol 2015 65 1385 1394. doi: 10.1016/j.jacc.2015.01.044.
18. Lip GY, Skjøth F, Rasmussen LH, Nielsen PB, Larsen TB, Net clinical benefit for oral anticoagulation, aspirin, or no therapy in nonvalvular atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex). J Am Coll Cardiol 2015 66 488 490. doi: 10.1016/j.jacc.2015.05.044.
19. Hart RG, Pearce LA, Aguilar MI, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007 146 857 867
20. Senoo K, Lip GY, Lane DA, Büller HR, Kotecha D, Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS Trial. Stroke 2015 46 2523 2528. doi: 10.1161/STROKEAHA.115.009487.
21. Lip GY, Skjoth F, Nielsen PB, Larsen TB, Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score: a comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy. Thromb Haemost 2015 114 826 834. doi: 10.1160/TH15-07-0565.
22. Lip GY, The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol 2011 8 602 606. doi: 10.1038/nrcardio.2011.112.
23. Lane DA, Lip GY, Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation. Thromb Haemost 2014 111 381 383. doi: 10.1160/TH14-01-0063.
24. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, ACC/AHA Task Force Members 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014 130 2071 2104. doi: 10.1161/CIR.0000000000000040.